BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 10204099)

  • 1. Diagnostic significance of papillary structures and intranuclear inclusions in Hurthle-cell neoplasms of the thyroid.
    Blumenfeld W; Nair R; Mir R
    Diagn Cytopathol; 1999 Apr; 20(4):185-9. PubMed ID: 10204099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Papillary Hürthle cell carcinoma (Warthin-like tumor) of the thyroid. Report of a case with fine needle aspiration findings.
    Vasei M; Kumar PV; Malekhoseini SA; Kadivar M
    Acta Cytol; 1998; 42(6):1437-40. PubMed ID: 9850656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?
    Pu RT; Yang J; Wasserman PG; Bhuiya T; Griffith KA; Michael CW
    Diagn Cytopathol; 2006 May; 34(5):330-4. PubMed ID: 16604553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fine-needle aspirations of papillary carcinoma with oncocytic features: an expanded cytologic and histologic profile.
    Renshaw AA
    Cancer Cytopathol; 2011 Aug; 119(4):247-53. PubMed ID: 21400667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hurthle cells in fine needle aspiration cytology of the thyroid: a potential diagnostic dilemma?
    Wong YP; Md Isa N; Md Zin RR; Noor Akmal S
    Malays J Pathol; 2015 Apr; 37(1):49-52. PubMed ID: 25890614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fine-needle aspiration biopsy of Hurthle cell lesions of the thyroid gland: A cytomorphologic study of 139 cases with statistical analysis.
    Elliott DD; Pitman MB; Bloom L; Faquin WC
    Cancer; 2006 Apr; 108(2):102-9. PubMed ID: 16453320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD44 immunostaining of thyroid fine-needle aspirates differentiates thyroid papillary carcinoma from other lesions with nuclear grooves and inclusions.
    Chhieng DC; Ross JS; McKenna BJ
    Cancer; 1997 Jun; 81(3):157-62. PubMed ID: 9196014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Papillary Hürthle cell tumor of thyroid: report of a case with a cytomorphologic approach to diagnosis.
    Dziecioł J; Musiatowicz B; Zimnoch L; Kemona A; Sulkowski S
    Acta Cytol; 1996; 40(2):311-4. PubMed ID: 8629418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of specific patterns on the sensitivity for follicular and Hurthle cell carcinoma in thyroid fine-needle aspiration.
    Renshaw AA; Gould EW
    Cancer Cytopathol; 2016 Oct; 124(10):729-736. PubMed ID: 27322887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hürthle cell lesions on thyroid fine needle aspiration cytology: Molecular and histologic correlation.
    Schatz-Siemers N; Brandler TC; Oweity T; Sun W; Hernandez A; Levine P
    Diagn Cytopathol; 2019 Oct; 47(10):977-985. PubMed ID: 31293091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytopathology of papillary carcinoma of the thyroid by fine needle aspiration.
    Kini SR; Miller JM; Hamburger JI; Smith MJ
    Acta Cytol; 1980; 24(6):511-21. PubMed ID: 6255716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intranuclear cytoplasmic inclusions in aspirates of follicular neoplasms of the thyroid. A report of two cases.
    Glant MD; Berger EK; Davey DD
    Acta Cytol; 1984; 28(5):576-80. PubMed ID: 6592919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psammoma bodies in fine-needle aspirates of the thyroid: predictive value for papillary carcinoma.
    Ellison E; Lapuerta P; Martin SE
    Cancer; 1998 Jun; 84(3):169-75. PubMed ID: 9678732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence-based criteria for adequacy in thyroid fine-needle aspiration.
    Renshaw AA
    Am J Clin Pathol; 2002 Oct; 118(4):518-21. PubMed ID: 12375637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and incidence of cytoplasmic yellow bodies in thyroid neoplasms.
    Rothenberg HJ; Goellner JR; Carney JA
    Arch Pathol Lab Med; 2003 Jun; 127(6):715-7. PubMed ID: 12741896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytomorphologic Spectrum of Hurthle Cell Lesions of Thyroid: A Study of 54 Cases.
    Anila KR; Nayak N; George PS; Jayasree K
    Gulf J Oncolog; 2018 Jan; 1(26):6-10. PubMed ID: 29607815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does the fine-needle aspiration diagnosis of "Hürthle-cell neoplasm/follicular neoplasm with oncocytic features" denote increased risk of malignancy?
    Giorgadze T; Rossi ED; Fadda G; Gupta PK; Livolsi VA; Baloch Z
    Diagn Cytopathol; 2004 Nov; 31(5):307-12. PubMed ID: 15468114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fine-needle aspiration diagnosis of the follicular variant of papillary carcinoma.
    Goodell WM; Saboorian MH; Ashfaq R
    Cancer; 1998 Dec; 84(6):349-54. PubMed ID: 9915136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fine-needle aspiration of papillary thyroid carcinoma: distinguishing between cases that performed well and those that performed poorly in the College of American Pathologists Nongynecologic Cytology Program.
    Renshaw AA; Wang E; Haja J; Wilbur D; Henry MR; Hughes JH;
    Arch Pathol Lab Med; 2006 Apr; 130(4):452-5. PubMed ID: 16594737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intranuclear cytoplasmic inclusions (invaginations) in thyroid aspirations. Frequency and specificity.
    Christ ML; Haja J
    Acta Cytol; 1979; 23(4):327-31. PubMed ID: 231366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.